Viking Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.11.24	Viking Therapeutics Stock Climbs On Positive Data From VK2735 Obesity Program (RTTNews)
04.11.24	Viking Therapeutics' Obesity Drug Data Shows Promising Early Results (RTTNews)
09.10.24	Viking Therapeutics Reports Positive Data From Phase 1b Study Of VK0214 In X-ALD (RTTNews)
04.06.24	Viking Therapeutics Reports Positive 52-week Histologic Data From Phase 2b VOYAGE Study Of VK2809 (RTTNews)
26.03.24	Viking Therapeutics Reports Positive Results From Phase 1 Study Of VK2735 In Obesity (RTTNews)
29.02.24	Viking Therapeutics Prices Public Offering Of About 6.47 Mln Shares At $85/shr (RTTNews)
27.02.24	Viking Therapeutics Announces Positive Top-Line Results From Phase 2 Venture Trial Of VK2735 (RTTNews)
08.08.23	Pre-market Movers: MTAC, AYX, DDOG, IFF, CHGG… (RTTNews)
26.07.23	Viking Therapeutics, Inc. Q2 loss in line with estimates (RTTNews)
26.04.23	Did You Catch These Biotech High-Flyers Before They Hit New Highs Yesterday? (RTTNews)
30.03.23	Viking Therapeutics Prices 17.24 Mln Share Offering (RTTNews)
28.03.23	Pre-market Movers: VKTX, IMRX, OSCR, WISA, ITCI… (RTTNews)
28.03.23	Viking Therapeutics: Phase 1 VK2735 Clinical Trial Reports Positive Results (RTTNews)
02.01.23	Ascletis Pharma Says Viking's Complaints On Drug Candidates ASC41 And ASC43F No Merit (RTTNews)
19.12.22	Pre-market Movers: MDGL, VKTX, IPHA, LANV, GOSS… (RTTNews)
27.10.22	BMRN Faces FDA In March, ALGN's Q3 Results Disappoint, VKTX Awaits VOYAGE… (RTTNews)
19.07.22	Viking Says FDA Lifts Clinical Hold On Phase 1b Trial Of VK0214 In Patients With X-ALD (RTTNews)
24.01.22	Viking Therapeutics Says FDA Places Clinical Hold On Phase 1b Trial Of VK0214 - Quick Facts (RTTNews)
01.11.21	Viking Therapeutics Reports Promising Preclinical Data On Dual GLP-1/GIP Agonists (RTTNews)
28.07.21	Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update (PR Newswire)
21.07.21	Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021 (PR Newswire)
24.06.21	Viking Therapeutics Announces Initiation of Phase 1b Clinical Trial of VK0214 in Patients with X-ALD (PR Newswire)
17.06.21	Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Novel Oral Thyroid Receptor Beta Agonist VK0214 (PR Newswire)
10.06.21	Viking Therapeutics to Participate in Upcoming Investor Conferences (PR Newswire)
29.09.20	Pre-market Movers In Healthcare Sector: TNXP, SRNE, GNFT, INO, HUGE… (RTTNews)
30.07.20	ALEC Falls Despite Promising Results, DNLI Makes Progress In COVID-19 Trial, EARS, ONTX On Watch (RTTNews)
05.04.19	MACK Halts MM-310 Study, VKTX On Watch, NAII Hits New High (RTTNews)
13.02.19	5 Top Gainers In Healthcare Sector (CASM, VKTX, ADMA...) (RTTNews)
22.09.18	Week Ahead In Pharmaceuticals: 10 Stocks To Watch (CKPT, SNDX, ADMP...) (RTTNews)
18.09.18	Viking Stock Surges As Liver Disease Drug Succeeds In Phase 2 Study (RTTNews)
24.08.18	OBLN Gaining Weight, CHFS On Track, EIDX On Watch, VKTX Up 178% YTD (RTTNews)
10.08.18	SPRO To Report Data In Q3, ITRM Takes Steady And SURE Steps, PBYI On Watch (RTTNews)
20.06.18	MassRoots Launches Revamped Dispensary Portal, Capable of Serving 2,400+ Licensed Dispensaries in Key Cannabis Markets (PR Newswire)
06.06.18	BIIB's Alzheimer's Drug Scores Well, EXAS Heads Higher, VXRT Down But Not Out (RTTNews)
05.06.18	Viking Therapeutics Completes Enrollment in Phase 2 Study of VK2809 in Patients with Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease (PR Newswire)
01.06.18	NASH Data Drives MDGL To The Moon, VKTX Turns Head, FDA Nod For KTOV (RTTNews)
17.05.18	EBIO Gets New Name, Time To Check CHEK, ABAX Snapped Up, GNPX Up 34% In 2 Days (RTTNews)
09.05.18	Viking Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update (PR Newswire)
07.05.18	Recursion Pharmaceuticals Receives Grant to Leverage AI-Enabled Discovery Platform in Infectious Disease (PR Newswire)
02.05.18	Viking Therapeutics to Report Financial Results for First Quarter 2018 on May 9, 2018 (PR Newswire)
07.03.18	Viking Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update (PR Newswire)
06.03.18	Viking Therapeutics to Present at Upcoming Investor Conferences (PR Newswire)
28.02.18	Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2017 on March 7, 2018 (PR Newswire)
07.02.18	Viking Therapeutics to Present at 2018 BIO CEO & Investor Conference (PR Newswire)
07.02.18	GILD's Sales Wane, SGMO Safe With CHAMPIONS, All's Not Well With Veterinarians? (RTTNews)
01.02.18	Strategikon Advances Planning and Financial Management for Life Sciences with Launch of Clinical Maestro™ (PR Newswire)
16.01.18	The Race To Find A Treatment For NASH (RTTNews)
02.01.18	Viking Therapeutics to Present at Biotech Showcase 2018 (PR Newswire)
11.12.17	Viking Therapeutics Announces Closing of Public Offering of Common Stock (PR Newswire)
05.12.17	Viking Therapeutics Announces Proposed Public Offering of Common Stock (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Viking Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten